Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells

Por Pan, Chun-Hao, Chang, Ying-Fang, Lee, Ming-Shuo, Wen, B-Chen, Ko, Jen-Chung, Liang, Sheng-Kai, Liang, Mei-Chih
Publicado no BMC Cancer (2016)

Keratin 17 identifies the most lethal molecular subtype of pancreatic cancer

Por Roa-Peña, Lucia, Leiton, Cindy V., Babu, Sruthi, Pan, Chun-Hao, Vanner, Elizabeth A., Akalin, Ali, Bandovic, Jela, Moffitt, Richard A., Shroyer, Kenneth R., Escobar-Hoyos, Luisa F.
Publicado no Sci Rep (2019)

An unbiased high‐throughput drug screen reveals a potential therapeutic vulnerability in the most lethal molecular subtype of pancreatic cancer

Por Pan, Chun‐Hao, Otsuka, Yuka, Sridharan, BanuPriya, Woo, Melissa, Leiton, Cindy V., Babu, Sruthi, Torrente Gonçalves, Mariana, Kawalerski, Ryan R., K. Bai, Ji Dong, Chang, David K., Biankin, Andrew V., Scampavia, Louis, Spicer, Timothy, Escobar‐Hoyos, Luisa F., Shroyer, Kenneth R.
Publicado no Mol Oncol (2020)

The PHLPP2 phosphatase is a druggable driver of prostate cancer progression

Por Nowak, Dawid G., Katsenelson, Ksenya Cohen, Watrud, Kaitlin E., Chen, Muhan, Mathew, Grinu, D’Andrea, Vincent D., Lee, Matthew F., Swamynathan, Manojit Mosur, Casanova-Salas, Irene, Jibilian, Megan C., Buckholtz, Caroline L., Ambrico, Alexandra J., Pan, Chun-Hao, Wilkinson, John E., Newton, Alexandra C., Trotman, Lloyd C.
Publicado no J Cell Biol (2019)